Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Total 13F shares
-
60,660,143
-
Share change
-
-2,353,424
-
Total reported value
-
$1,645,431,741
-
Put/Call ratio
-
53%
-
Price per share
-
$27.12
-
Number of holders
-
162
-
Value change
-
-$123,990,833
-
Number of buys
-
83
-
Number of sells
-
72
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q4 2024
As of 31 Dec 2024,
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,660,143 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, JANUS HENDERSON GROUP PLC, Capital Research Global Investors, Deep Track Capital, LP, Driehaus Capital Management LLC, FEDERATED HERMES, INC., BVF INC/IL, Vestal Point Capital, LP, and Capital International Investors.
This page lists
163
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.